Leverkusen, Germany

Markus Osterloh

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Markus Osterloh

Introduction

Markus Osterloh is a prominent inventor based in Leverkusen, Germany. He has made significant contributions to the field of photodynamic therapy, with a focus on developing advanced illumination devices. With a total of 7 patents to his name, Osterloh's work is paving the way for innovative treatments in medical technology.

Latest Patents

Among his latest patents is an illumination device specifically designed for photodynamic therapy. This device includes at least one electromagnetic radiation emitting unit, which is equipped with an electromagnetic radiation source. The purpose of this device is to generate radiation for the irradiation of a designated area on an irradiation object during an illumination session. The design ensures that the irradiation object is positioned at a predetermined location, maintaining a specific distance from the radiation output area of the emitting unit. This innovative approach enhances the effectiveness of photodynamic therapy.

Career Highlights

Markus Osterloh is currently employed at Biofrontera Pharma GmbH, where he continues to develop groundbreaking technologies in the medical field. His expertise in photodynamic therapy has positioned him as a key figure in advancing treatment options for skin diseases.

Collaborations

Throughout his career, Osterloh has collaborated with notable colleagues, including Ben Novak and Hermann Lübbert. These partnerships have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.

Conclusion

Markus Osterloh's contributions to the field of photodynamic therapy exemplify the impact of innovative thinking in medical technology. His patents and ongoing work at Biofrontera Pharma GmbH highlight the importance of advancements in treatment methods for skin diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…